Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 2, 2018
Reporting Period: Three months ended March 31, 2018
This filing serves as a notification that the company issued a press release announcing financial results for the first quarter of fiscal year 2018. The detailed financial data is contained in Exhibit 99.1 (Press Release), which is incorporated by reference but explicitly stated as not "filed" for purposes of Section 18 of the Exchange Act.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data. The following metrics are referenced as being available in the attached press release (Exhibit 99.1) but are not present in this document:
- Revenue
- Profit (Net Income/Loss)
- Cash Flow
- Margins
- Debt and Liquidity
Note: The filing text does not provide a clear value for any specific financial metric.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It only confirms that results for the three months ended March 31, 2018, were announced.
Guidance, Outlook, and Risks
Management Commentary: The company announced a conference call to be held at 4:30 PM EST on May 2, 2018, to discuss the results.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, earnings, and cash flow figures.
- Verify the details of the conference call held on May 2, 2018, for management commentary on the results.
- Confirm the specific reasons for any variances in financial performance compared to the prior year quarter.
- Check subsequent filings (e.g., 10-Q) for audited or reviewed financial statements, as this 8-K only references a press release.